Protection against painful shingles isn't the only reason to get vaccinated. New research shows the shot could also shield your heart for up to eight years, especially if you're under 60.

The release of Pretty Hurts comes two years after GSK collaborated with Lifetime on a short film highlighting the risks associated with meningitis B.

A new project will use electronic health data from the UK’s National Health Service to assess the impact of GSK’s shingles ...

"To enroll our first patients just over two months after announcing our $110 million Series B round demonstrates the Curevo ...

If you've ever had chickenpox in your childhood, chances are you're likely to develop shingles in the future. While people might assume that shingles — a painful, blistering rash — only ...

The only shingles vaccine on the market in South Africa was discontinued in 2024. A newer and better vaccine is being used in ...

The only shingles vaccine on the market in South Africa was discontinued last year. A newer and better vaccine is being used ...

Researchers found people given a shingles vaccine had a 23% lower risk of cardiovascular events, including stroke, heart ...

Researchers investigated whether the shingles (herpes zoster) vaccine can help prevent dementia ... Price Action: GSK stock is up 3.71% at $39.04 at the last check Thursday.

LONDON (Reuters) -GSK (GSK.L) said on Tuesday that it is studying a group of more than a million older adults in the UK to examine whether its best-selling shingles vaccine lowers the risk of dementia ...

GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for ...